Duravant Announces Retirement of CEO Mike Kachmer, Names Jill Evanko Successor
17.11.2025 16:13:00 CET | Business Wire | Press Release
Duravant LLC (“Duravant”), a global leader in advanced automation solutions, announced today that Mike Kachmer will retire from his role as Chief Executive Officer after a highly successful tenure with the company. Duravant’s Board of Directors has named Jill Evanko as CEO, joining the company on January 5, 2026. To ensure a seamless transition, Mr. Kachmer will continue to serve as Chairman of Duravant. Mr. Kachmer will also continue to serve on the Board of Directors for Northwestern Memorial Healthcare and The London Clinic.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251117036720/en/
Mike Kachmer
“It has been a true honor and a humbling experience to lead this incredible company,” said Mr. Kachmer. “I am profoundly grateful to my colleagues within Duravant for their support over the years. Together, we have built an organization with a truly differentiated operating model and culture, one that cultivates collaboration, empowers innovation, and operates with unwavering integrity.”
Jill Evanko joins Duravant from Chart Industries, Inc. (NYSE: GTLS) where she served as President and Chief Executive Officer since 2018. Prior, Ms. Evanko was the Chief Financial Officer of Truck-Lite Co. LLC, and held multiple executive leadership positions at Dover Corporation (NYSE: DOV) and its subsidiaries. Earlier in her career, she held financial and operational roles at Arthur Andersen LLP, Honeywell Corporation and Sony Corporation. Ms. Evanko received a Master of Business Administration degree from The University of Notre Dame and a Bachelor of Science degree in Business Administration from La Salle University. Ms. Evanko also serves as an independent director of the Board of Greif, Inc. (NYSE: GEF, GEF.B)
“It is a privilege to join Duravant and build upon the remarkable foundation established by Mike,” said Jill Evanko. “I’m grateful to him for the strong legacy of excellence he leaves behind, and I’m excited to work with this exceptional team to advance our mission and shape Duravant’s next chapter of success.”
Under Mr. Kachmer’s leadership, Duravant emerged as a prominent player in the industrial automation sector. Mr. Kachmer led the company’s transformation through 30 acquisitions and strategic partnerships and set the company’s vision to expand into new market segments. He also grew Duravant’s global footprint throughout the Americas, Europe, and Asia and strengthened its position in emerging markets with the establishment of sales and service centers in Brazil, Mexico, China, Thailand, and India.
“Mike’s retirement will mark the end of a remarkable career with Duravant. With his vision steering the company, Duravant has delivered unrivaled growth driven by innovation, operational excellence, and a fine-tuned customer focus,” said Jeff Goldfaden, Managing Director and Head of Industrials at Warburg Pincus and member of Duravant’s Board of Directors. “We are looking forward to welcoming Jill as Duravant’s next CEO. Her strategic mindset and extensive leadership experience at best-in-class industrials companies position her to build upon Duravant’s core strengths and lead the company’s future success.”
“On behalf of the Board, I’d like to extend our deep appreciation to Mike for his unwavering commitment and outstanding service to Duravant. His leadership and strategic direction have been instrumental in shaping the company into the high performing organization it is today,” said Wes Bieligk, Partner at Carlyle and member of Duravant’s Board of Directors. “We’re excited to welcome Jill to Duravant. Her deep expertise and accomplishments reflect the same commitment to excellence and collaboration that define Duravant.”
“Looking ahead, I am delighted that Jill will succeed me as CEO,” said Mr. Kachmer. Her extensive experience, demonstrated capabilities, and winning spirit make her the perfect person to lead Duravant forward. I am confident that Jill and her leadership team will continue to build on our strong foundation and take Duravant to new heights.”
About Duravant
Duravant is a global leader in advanced automation solutions operating across the food processing, packaging, and material handling industries. Founded on more than a century of expertise, Duravant delivers performance-driven technologies, integrated systems and full lifecycle services that drive productivity, efficiency and safety for the world’s producers and movers of high demand goods. The company serves a broad range of essential end markets including food & beverage, agriculture, consumer and industrial goods, e-commerce, and logistics. Headquartered in Downers Grove, Illinois, and serving customers in more than 190 countries, Duravant unites a portfolio of leading brands under a shared commitment to quality, innovation and customer success. For more information, visit www.duravant.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251117036720/en/
Contacts
Duravant Media Contact:
Eleni Yianas
Sr. Vice President, Marketing
Eleni.yianas@duravant.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press Release
Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima
Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 16:25:00 CEST | Press Release
Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy
Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press Release
A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio
The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press Release
Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press Release
Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom